Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Apo-Sertraline
Active Ingredient: Sertraline hydrochloride 111.8mg equivalent to 100mg sertraline
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Etobicoke, Ontario, Canada
Product: Apo-Sertraline
Active Ingredient: Sertraline hydrochloride 55.9mg equivalent to 50mg sertraline
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Etobicoke, Ontario, Canada
Product: Gelafusal
Active Ingredients: Succinylated gelatin 40g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Biomed Limited
Manufacturer: Serumwerk Bernburg AG, Bernburg, Sachsen-Anhalt, Germany
Product: Levothyroxine
Active Ingredient: Levothyroxine sodium, anhydrous 50µg
Dosage Form: Tablet
New Zealand Sponsor: Boucher & Muir New Zealand Limited t/a Goldshield Healthcare (New Zealand)
Manufacturer: Custom Pharmaceuticals Limited (UK), Brighton, East Sussex, United Kingdom
Product: Levothyroxine
Active Ingredient: Levothyroxine sodium, anhydrous 100µg
Dosage Form: Tablet
New Zealand Sponsor: Boucher & Muir New Zealand Limited t/a Goldshield Healthcare (New Zealand)
Manufacturer: Custom Pharmaceuticals Limited (UK), Brighton, East Sussex, United Kingdom
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 100µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 112µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 125µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 137µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 150µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 175µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 200µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 25µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 300µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 50µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 75µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 88µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Dated this 16th day of October 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).